Vietnam Clinical Nutrition for Cancer Care Market Report 2023 to 2030

Vietnam Clinical Nutrition for Cancer Care Market Analysis

$ 3999

The Vietnam Clinical Nutrition for Cancer Care Market was valued at $28.1 Mn in 2023 and is predicted to grow at a CAGR of 5.27% from 2023 to 2030, to $40.3 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. The prominent players of the Vietnam Clinical Nutrition for Cancer Care Market are Fonterra, FriesLand Campina, Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.

ID: IN10VNPH565 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Aarti Patel

Buy Now

Vietnam Clinical Nutrition for Cancer Care Market Executive Summary

The Vietnam Clinical Nutrition for Cancer Care Market was valued at $28.1 Mn in 2023 and is predicted to grow at a CAGR of 5.27% from 2023 to 2030, to $40.3 Mn by 2030.

Clinical nutrition for cancer care is a specialized field focusing on providing optimal nutritional support to patients throughout their cancer journey. It goes beyond simply “eating healthy” and involves a personalized approach to address the unique nutritional needs of each patient. A registered dietitian or other qualified healthcare professional usually assess the patient’s nutritional status. Based on the assessment, a personalized plan is created to meet the patient’s individual needs. Nutritional deficiencies are prevalent among cancer patients due to treatment side effects, altered metabolism, and decreased appetite. Clinical nutrition interventions play a crucial role in improving treatment tolerance as adequate nutrition can help patients tolerate chemotherapy and radiation therapy better, potentially reducing side effects and allowing for completion of treatment plans. Also, it maintains strength and immunity as proper nutrition helps patients maintain muscle mass, fight infections, and recover faster from surgery. Lastly, it enhances the quality of life since nutritional support can improve fatigue, appetite, and overall well-being, leading to a better quality of life during cancer treatment.

Advancements in medical nutrition therapy have led to the development of specialized oral nutritional supplements (ONS) and enteral feeding formulas. These products provide concentrated nutrients and can be crucial for patients struggling to meet their nutritional needs through regular diet alone. Parenteral nutrition remains an option for patients unable to tolerate oral or enteral feeding. Overall, clinical nutrition for cancer care plays a vital role in optimizing patient outcomes by ensuring they receive the necessary nutrients to support their body throughout treatment.

The Vietnam Clinical Nutrition for Cancer Care Market is driven by significant factors such as the increasing prevalence of cancer, improved healthcare infrastructure, and rising disposable incomes. However, reimbursement policies, limited awareness, and challenges in implementation restrict the growth and potential of the market.

The major players of the Vietnam Clinical Nutrition for Cancer Care Market are Fonterra, FriesLand Campina, Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others.

Vietnam Clinical Nutrition for Cancer Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Cancer: A major driver for this market is the increasing global burden of cancer and the high mortality rates associated with it. As the population ages and lifestyle risks like smoking persist, the number of new cancer cases diagnosed each year continues to rise. Cancer as a cause of death has been constantly increasing in Vietnam and has become the leading cause of death. According to the WHO data, Vietnam has about 165 000 new cancer cases and about 115 000 cancer deaths each year. The age-standardized rate of cancer mortality in Viet Nam is 104 (per 1,00,000 population) rank 57 globally. This translates to a larger patient population requiring specialized nutritional support during treatment, which in turn drives the Clinical Nutrition for Cancer Care Market further.

Improved Healthcare Infrastructure: With the establishment of new hospitals and specialist cancer care clinics, Vietnam’s healthcare infrastructure is improving. These facilities have departments or staff specializing in clinical nutrition for cancer patients. These departments can provide comprehensive nutritional assessments, develop personalized nutrition plans, and offer specialized services like enteral and parenteral nutrition support. Improved infrastructure facilitates the adoption of advanced medical technologies for cancer diagnosis and treatment. These advanced treatments, like complex surgeries or radiation therapy, often require specialized nutritional support to manage side effects and optimize patient recovery. Improved health infrastructure plays a vital role in propelling the Vietnam Clinical Nutrition for Cancer Care Market by creating a conducive environment for specialized services, fostering advanced treatment approaches, and facilitating collaboration among healthcare professionals.

Rising Disposable Incomes: As disposable incomes rise, Vietnamese households have more money to allocate towards healthcare. This translates into a greater willingness to pay for specialized services like clinical nutrition for cancer care. Previously, patients might have relied solely on traditional remedies or basic nutritional support due to financial constraints. Increased disposable income allows them to consider additional services that can improve treatment outcomes and quality of life. Consequently, rising disposable incomes can lead to a growing demand for personalized and comprehensive cancer care plans. Clinical nutrition plays a crucial role in achieving this by tailoring nutritional plans to individual needs and preferences. Patients might be more willing to invest in services that offer a more holistic approach to cancer care, including personalized nutritional support. Thus, rising disposable incomes in Vietnam allows patients to invest in specialized services like clinical nutrition for cancer care which ultimately drives the growth of the Vietnam Clinical Nutrition for Cancer Care Market.

Market Restraints

Varied reimbursement policies: Reimbursement policies for nutritional support products like oral nutritional supplements (ONS) and enteral feeding formulas differ significantly across regions and even within healthcare systems. This can create access disparities for patients, particularly in areas with limited coverage or complex procedures for reimbursement. Thus, due to cost and reimbursement issues, the Clinical Nutrition for Cancer Care Market might not grow to its full potential.

Limited Awareness: While awareness is increasing, not all healthcare professionals may fully understand the significance of clinical nutrition in cancer care. This can lead to underutilization of nutritional support services and a failure to identify patients who could benefit from them. Some patients might not be fully aware of the benefits of proper nutrition during cancer treatment and the available support options. Therefore, the limited awareness can prevent the Clinical Nutrition for Cancer Care Market from growing.

Challenges in Implementation: The trend towards personalized nutrition plans requires adequate resources and support systems to effectively implement these plans for each patient after consideration of many factors. Also, seamlessly integrating clinical nutrition services into existing healthcare workflows can be challenging. This might require changes in practice patterns and fostering collaboration among different healthcare professionals. These changes in the healthcare structure can be hard to incorporate thus acting as a restraint for the Clinical Nutrition for Cancer Care Market.

Regulatory Landscape and Reimbursement Scenario

The Drug Administration of Vietnam (DAV) is the regulatory agency for pharmaceuticals in the Vietnam. It operates under the Ministry of Health (MoH) and plays a critical role in ensuring the safety, efficacy, and quality of pharmaceutical products available in the country.

Before new pharmaceuticals are allowed to be sold in Vietnam, the DAV meticulously examines applications and authorizes their marketing. It also registers distributors, wholesalers, and producers of pharmaceuticals. Moreover, strict quality control procedures are implemented to guarantee the security and effectiveness of medications. This includes examinations of production sites, implementing quality control measures, and maintaining labs for product testing. The rigorous review and oversight by DAV procedures help guarantee that only safe and effective medications are available to Vietnamese consumers.

Vietnam’s healthcare system offers a mix of public and private financing option. The Social Health Insurance (SHI) is a program that is required for all employees in the formal sector, as well as their dependents. SHI offers discounted medical care at specific public and private establishments. Pregnancy care, some outpatient services, hospital stays, and prescription drugs are partially paid for by SHI. Private Health Insurance is an optional add-on offering wider coverage and potentially higher reimbursement rates compared to SHI. Compared to SHI, private health insurance plans cover a broader range of services including advanced diagnostics and procedures, private hospitals and specialists, shorter waiting times, and outpatient care.

Competitive Landscape

Key Players

Here are some of the major key players in the Vietnam Clinical Nutrition for Cancer Care Market:

Nestlé Health Science
Abbott Nutrition
Fonterra
FriesLand Campina
B. Braun Melsungen AG
Fresenius Kabi
Danone Nutrica
Baxter International Inc.
Victus Inc.
Mead Johnson Nutrition
Aymes

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Clinical Nutrition for Cancer Care Market Segmentation

By Type

Oral Nutrition
Parenteral Nutrition
Enteral Feeding Formulas

By Cancer Type

Head & Neck Cancer
Stomach & Gastrointestinal Cancer
Blood Cancer
Breast Cancer
Lung Cancer
Others

By Age Group

Adult
Paediatric

By Sales Channel

Offline
Online

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.